What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
The Income Tax Department has appealed to the Income Tax Appellate Tribunal (ITAT) in New Delhi against tax relief granted to Dr Lal PathLabs over ₹32,66,18,927 in employee stock option (ESOP) expenses for Assessment Year 2022–23. The appeal challenges a Commissioner of Income Tax (Appeals) order; the report does not say that ITAT has ruled on the matter.
What is the dispute about?
The case concerns ₹32,66,18,927 in ESOP expenses—about ₹32.66 crore—that had been disallowed. The Commissioner of Income Tax (Appeals), in an order under Section 250 of the Income Tax Act, 1961, granted Dr Lal PathLabs relief against that disallowance for Assessment Year 2022–23.
The department is now challenging that relief before ITAT, New Delhi. The reported amount is the expense at issue, not a final tax liability or an amount the company has been ordered to pay.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteWhen did the appeal become known?
According to an Economic Times/PTI report published on 9 October 2026, Dr Lal PathLabs said it received an intimation on Wednesday, 7 October, that the department had appealed. The company made a regulatory filing about the matter.
#1 Best Overall
Has ITAT ruled, and what happens next?
The report confirms that an appeal was filed, but it gives no ITAT decision, appeal number, listing information, or hearing date. It also does not provide the department’s detailed grounds of appeal or the CIT(A)’s reasoning for granting relief. The outcome therefore cannot be determined from the reported information.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What does Dr Lal PathLabs expect the impact to be?
The company said it “does not reasonably expect the outcome of the appeal to have any material impact” on it. This is the company’s assessment, not a tribunal finding or a prediction of the appeal’s outcome.
Quick Recap
Best Value
Rank #3
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Free tools Windows power users keep installed
One-click scans. No signup required.
